| Term 
 
        | Recognize the names of the antimalarialdrugs |  | Definition 
 
        | Anti-malarials : 1. Quinine; Quinidine ( No brand name), 2. Chloroquin (Aralen),
 3. Primaquin ( No Brand name),
 4 Mefloquin ( Larium),
 5. Pyrimethamine ( Daraprim),
 6 Sulfadoxine/pyrimethamine ( Fansidar),
 7. atorvaquone/proquanil ( Malarium)
 8. artemether/lumefantrine (coartem)
 State use and mechanism of action - quinine	Quinine, Only anti malarial in the 1920's, Less potency but has re-emerged due to resistance which develops less readily.
 Mechanism: Intercalates into DNA of Parasite. This disrupts the parasites replication and transcription
 State use and mechanism of action - chloroquin	Chloroquin ( Aralen), Mechanism: Sketchy - interfers with metabolism and hemoglobin utilization by the parasites.
 |  | 
        |  | 
        
        | Term 
 
        | State use and mechanism of action - quinine |  | Definition 
 
        | Quinine, Only anti malarial in the 1920's, Less potency but has re-emerged due to resistance which develops less readily.  Mechanism: Intercalates into DNA of Parasite. This disrupts the parasites replication and transcription |  | 
        |  | 
        
        | Term 
 
        | State use and mechanism of action - chloroquin |  | Definition 
 
        | Chloroquin ( Aralen), Mechanism: Sketchy - interfers with metabolism and hemoglobin utilization by the parasites.    Resistance: Resistance is widespread through sub-saharan africa and S. America due to the decrease in accumulation in the food vavuole by decreased uptake. |  | 
        |  | 
        
        | Term 
 
        | State use and mechanism of action - pryimethamine |  | Definition 
 
        | Pyrimethamine ( Daraprim)  Use: Both prophylaxis and treatment of P. Falciparum.  Mechanism: Inhibits dihydrofolate reductase and synthesis of folic acid. |  | 
        |  | 
        
        | Term 
 
        | What is coartem? Use? Mechanism |  | Definition 
 
        | Artemether and Lumefantrine ( Coartem)  Use: Treatment of acute , uncomplicated infections due to P. Falciparum.  Mechanism : Exact mechanism unknown. May inhibit nucleic acid and protein syntesis |  | 
        |  | 
        
        | Term 
 
        | [Non-Objective] What species mosquito caries malaria? What is the parasite that causes Malaria |  | Definition 
 
        | Malaria is caused by Plasmodium, and is vectored by Anopheles mosquitoes |  | 
        |  | 
        
        | Term 
 
        | [Non-Objective] Treatment of TB must include two drugs to the orfanism is susceptible to. Treatment needs to continue until all clearance of lesions has occurred. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | What is the mechanism and use for Isoniazid? |  | Definition 
 
        | Isoniazid : Highly specific for mycobacteria. Bactericidal against actively growing bacilli. Exact mechanism unkown. Required activation by KatG or AhpC catalase-perioxidase to produce isonicotinic acyl-NADH.  Resistance due to: Mutation in KatG. |  | 
        |  | 
        
        | Term 
 
        | What is the mechanism and use for Rifampin? |  | Definition 
 
        | -Rifampin inhibits the DNA-dependent RNA Polymerase.  -Inhibits initiation of RNA synthesis but NOT THAT IS ALREADY IN PROGRESS prior to drug treatment.  -Does not inhbit DNA-RNA polymerase complex formation but INHIBITS TRANSLOCATION. Selectively toxic because mammalian RNA plymerases are not sensitive. Effective in preventing emergence of isoniazid resistance in combination therapy, although resistance to rifampin is on the rise it has a very high sterilizing activity . Useful in the reatment of pulmonary and extrapulmonary TB. |  | 
        |  | 
        
        | Term 
 
        | What is the mechanism and use for Pyrazinamde? |  | Definition 
 
        | Antitubercular agent,  -Use: Adjunctive treatment of tuberculosis in combination with isoniaxid or rifampin.  -Mechanism: Conversion to a drug metabolite in mycobacterium which lower pH with bacteria: exact mechanism not elucidated. |  | 
        |  | 
        
        | Term 
 
        | Be able to identify the names of the drugs within the following classes : Polyenes, |  | Definition 
 
        | POLYENES:  -[Amphotericin ]B - Injections, conventional ( Fungizone),   -Lipid complex form ( Ablecet),   -Colloidal suspension w/ cholesterol sulfate (Amphotec),   -Liposomal drug devlivery system (AmBisome),    -Nystatin.  |  | 
        |  | 
        
        | Term 
 
        | Describe the mechanism of antifungal action of polyenes. |  | Definition 
 
        | Cyclic macrolide lactones  (Amphotericins; Nystatin) - inhibit by binding to the cell mebrane. Preferentially binds to Describe the mechanism of antifungal action of polyenes.   ERGOSTEROL in fungal cytosolic membranes.    [Ergosterol is a major component of the fungal cell membrane. This binding forms PORES in the membrane leading to K+ LEAKAGE and subsequent death of the fungal cell. Ergosterol is unique to fungi.   BROAD SPECTRUM |  | 
        |  | 
        
        | Term 
 
        | Describe the mechanism of antifungal action of Flucytosine |  | Definition 
 
        | Describe the mechanism of antifungal action of Flucytosine   flucytosine (Ancobon)    ○ Interferes with RNA synthesis and protein synthesis in fungus        • Converted to 5-flurouracil (5-FU), which competitively interferes with fungal RNA/protein synthesis  ○ Works On: only Cryptococcus neoformans and agents of chromomycosis |  | 
        |  | 
        
        | Term 
 
        | Desccribe the mechanism of antifungal action of Azoles |  | Definition 
 
        | Desccribe the mechanism of antifungal action of Azoles   Inhibits Synthesis of Ergosterol (inhibits lanosterol 14alpha-demethylase).   lanosterol 14alpha-demethylase. -> lanosterol -> ergosterol -> fungal cytochrome P450 complex |  | 
        |  | 
        
        | Term 
 
        | Describe the mechanism of antifungal action of Echinocandins |  | Definition 
 
        | Inhibitor of cell wall synthesis  -inhibits Beta-(1,3) - D- Glucan synthase.   Mammalian cells do not require B-(1,3)-D-glucan,limiting drug toxicity. |  | 
        |  | 
        
        | Term 
 
        | Describe how nystatin is used in dentistry |  | Definition 
 
        | Describe how nystatin is used in dentistry   ○ Treats fungal infections caused by Candida in oral cavity and mucocutaneous membranes  ○ Applied topically   § When swallowed, is NOT absorbed from GI tract  ○ Typical Dental Dose  $400,000-600,000 liquid units, use 4x/day - swish and retain for as long as possible, then swallow   |  | 
        |  | 
        
        | Term 
 
        | Identify names of drugs within azoles, |  | Definition 
 
        | Identify names of drugs within azoles,   • Triazoles  □ Oral       Fluconazole - "Diflucan       Voriconazole - "Vfend"       Itraconazole - "Sporanox"    □ Topical       Terconazole - "Terazol"   • Imidazoles  □ Oral       Ketoconazole - "Nizoral"    □ Topical       Clotrimazole - "Lotrimin AF"       Micronazole - "Oravig"       Econazole - none |  | 
        |  | 
        
        | Term 
 
        | Identify names of drugs within flucytosine class |  | Definition 
 
        | • Flucytosine - "Ancoban" |  | 
        |  | 
        
        | Term 
 
        | ID names of drugs within echinocandins classes. |  | Definition 
 
        | • Caspofungin Acetate - "Cancidas" |  | 
        |  | 
        
        | Term 
 
        | Outline biosynthetic pathway for Ach |  | Definition 
 
        | 
Acetylcholine Synthesis & Release(General Overview)
"Acid + Alcohol --> Ester" 
Acetyl CoA + Choline --> Acetylcholine (Ach) 
Note: Esters are easily destroyed/broken down… so while Acetylcholine is a good agonist, it is readily destroyed via Acetylcholine esterase |  | 
        |  | 
        
        | Term 
 
        | Outline specific mechanism of Ach |  | Definition 
 
        | 
Specific Mechanism
2. & 3. Transporter to get Choline into neuron 
4. Cytosol: Acetyl CoA + Choline --(Ach Transferase)--> Ach 
5. Ach is transported into storage vesicle for  protection from breakdown 
6. Remains in storage until AP causes release of  Ach from vesicle 
7. AP is caused by influx of Ca2+ via voltage regulated  Channels --> causes Ach vesicle to fuse to synaptic membrane (Botulism Toxin blocks this step) 
8. Ach released into synaptic space 
9. Ach travels across synapse and binds to receptor Serves as an agonist Can bind to 2 types of receptors: 
G-Protein coupled receptorsIon channels 
10.  Ach's action is terminated by metabolism via Ach-esterase after it is released from receptors 
Sites of Action
Ach primarily binds to post-synaptic sites 
Ach can also bind to pre-synaptic sites
Help coordinate what is occurring pre-synaptically |  | 
        |  | 
        
        | Term 
 
        | 3. Describe the pre- and postsynaptic sites and mechanisms for potential drug action to affect colinergic neurotransmission. |  | Definition 
 
        | Cholinergic Receptors(Ach is the NT) 
Nicotinic
Ion-Channel ReceptorsSubtypes
Non-neuronal (skeletal muscle): Receptor present in the muscle for contractionNeuronal types: In immune cells, CNS and ganglia, where Ach is working Nicotine has high affinity for receptors located in:
Skeletal muscleAutonomic Ganglia and Adrenal MedullaSpinal cordBrain Ligand Gated Ion Channel
5 subunits: α2, β, γ, δ surround a central poreAch binds to α subunits --> channel opens--> Na+ passes through --> generates AP Muscarinic 
G-Protein Coupled ReceptorsSubtypes
M1, M3, M5 (IP3/DAG)M2, M4 (cAMP) Muscarine has high affinity for receptors located in:
Cardiac muscleSalivary glandsGI and Genitourinary smooth muscleSmooth muscle of arterioles and vein, and eye (pupillary sphincter & ciliary muscle)Brain Example: Muscarinic Signaling in Heart (M2)
Ach --> G-Protein Receptor (binding site if deep within G-Protein) --> α subunit separates, β & γ subunits stay together
α: inhibits ATP production by inhibiting adenylyl cyclase --> inhibits cAMP --> inhibits Ca2+ and Na+ channels from opening and causing the depolarization of the cellβ & γ: opens K+ channel, K+ leaves cell (membrane potential becomes hyperpolarized Overall: DECREASES HR (cell is hyperpolarized, thus decreasing the firing rate)Keep in mind: A Muscarinic receptor in a different tissue may do something entirely different…   Acetylcholine Esterase 
Performs the enzymatic hydrolysis and terminated of Ach
Happens in micro-seconds!! Mechanism
2 Parts to the Active Site:
1. Esteratic Site: binds to the ester part of Ach2. Anionic Site: binds to the N (bound to 3 C's) part of Ach Hydrolysis occurs --> splitting Ach
Choline can be reusedAcetate is then further metabolized/used by other systems |  | 
        |  | 
        
        | Term 
 
        | Outline the autonomic innervation and effects of cholinergic action at the (i) iris and ciliary musculature of the eye |  | Definition 
 
        | Eye
Iris
Opening regulated by radial muscles and pupillary sphincter musclesConstrictor muscle contraction: Miosis, via M3Radial dilator muscle contraction: Mydriasis, via α Ciliary Muscle
Regulates tension on suspensory ligaments that hold lensContraction: decreases tension and promotes lens thickening (accommodation for close vision), via M3Relaxation: closes off opening to Canal of Schlemm
Causes an increase in intraocular pressure by inhibiting outflow of aqueous humor from posterior chamber to anterior chamber --> results in glaucoma
Cholinergic agonists (causing contraction of ciliary muscle and Miosis) may treat glaucoma (ex. Pilocarpine -- see below)   
|   | Sympathetic Activity |   | Parasympathetic Activity |   |  
| Organ | Action1 | Receptor2 | Action | Receptor2 |  
| Eye |   |   |   |   |  
|     Iris radial/dilator muscle (Mydriasis) | Contracts | α1 |   |   |  
|     Iris circular/constrictor muscle (Miosis) | ... | α1 | Contracts | M3 |  
|     Ciliary muscle (hold lens in place) | [Relaxes] | β | Contracts | M |  |  | 
        |  | 
        
        | Term 
 
        | Outline the autonomic innervation and effects of cholinergic action at the(iii) heart (myocardium and conductive system),  |  | Definition 
 
        | Heart
Decrease force of contraction (iontropy) and rate of contraction (chronotropy -- main effect) via M2
Increase K+ permeability: hyperpolarizationDecrease Ca2+ permeability   
| 
 Heart |   |   |   |   |  
|     Sinoatrial node | Accelerates | β1, β2 | Decelerates | M2 |  
|     Ectopic pacemakers | Accelerates | β1,β2 | ... | ... |  
|     Contractility | Increases | β1,β2 | Decreases (atria) | M2 |  
|     Skin, splanchnic vessels | Contracts | α |   | ... |  
|     Skeletal muscle vessels | Relaxes | β2 | ... | ... |  
|   | [Contracts] | α | ... | ... |  
|   | Relaxes3 | M | ... | ... |  
|     Endothelium (drug effect) |   |   | Releases EDRF4 Due to release of Nitric Oxide (NO) This relaxes smooth muscle of endoth. | M3, M55 |  |  | 
        |  | 
        
        | Term 
 
        | Outline the autonomic innervation and effects of cholinergic action at the (2)  GI tract |  | Definition 
 
        | 
Increase secretory activity and peristalsis, relax sphincter  via M3 
 
 
| Gastrointestinal tract |   |   |   |   |  
|     Smooth muscle |   |   |   |   |  
|             Walls | Relaxes | α2,6β2 | Contracts | M3 |  
|             Sphincters | Contracts | α1 | Relaxes* | M3 |  
|     Secretion | ... | ... | Increases | M3 |  |  | 
        |  | 
        
        | Term 
 
        | Outline the autonomic innervation and effects of cholinergic action at the skin |  | Definition 
 
        | 
| Skin |   |   |   |   |  
|     Pilomotor smooth muscle | Contracts | α | ... | ... |  
|     Sweat glands |   |   | ... | ... |  
|             Eccrine | Increases | M | ... | ... |  
|             Apocrine (stress) | Increases | α | ... | ... |  |  | 
        |  | 
        
        | Term 
 
        | Outline the autonomic innervation and effects of cholinergic action at the metabolic functions |  | Definition 
 
        | 
| Metabolic functions |   |   |   |   |  
|     Liver | Gluconeogenesis | β2, α | ... | ... |  
|     Liver | Glycogenolysis | β2, α | ... | ... |  
|     Fat cells | Lipolysis | β3 | ... | ... |  
|     Kidney | Renin release | β1 | ... | ... |  |  | 
        |  | 
        
        | Term 
 
        | Outline the autonomic innervation and effects of cholinergic action at the genitourinary tract |  | Definition 
 
        | 
Increase contractility of bladder and relax sphincter: piss! via M3   
| 
 Genitourinary smooth muscle |   |   |   |   |  
|     Bladder wall | Relaxes | β2 | Contracts | M3 |  
|     Sphincter | Contracts | α1 | Relaxes | M3* |  
|     Uterus, pregnant | Relaxes | β2 | ... | ... |  
|   | Contracts | α | Contracts | M3 |  
|     Penis, seminal vesicles | Ejaculation | α | Erection | M |  |  | 
        |  | 
        
        | Term 
 
        | Outline the autonomic innervation and effects of cholinergic action at the bronchi |  | Definition 
 
        | Respiratory System
Increase smooth muscle contraction and glandular secretion via M3 (decreases brochi diameter)β2 receptors are also present on bronchial smooth muscle -- triggered by Epinephrine -- causes dilation   
| 
 Bronchiolar smooth muscle | Relaxes | β2 | Contracts | M3 |  |  | 
        |  | 
        
        | Term 
 
        | Outline the autonomic innervation and effects of cholinergic action at the CNS, PNS, and ganglia |  | Definition 
 
        | CNS 
M1, M2, Nn receptors are all present in CNS
This is why nicotine in tobacco has an effect Nicotine poisoning can occur (often from insecticides)
See tremor, emesis, convulsions, coma, even death Study results of treatment for quitting smoking
CHANTIX: 44% quit
Good because it's a partial agonist (person gets satisfied only to some extent) 
 PNS 
Nnand Nmare sites of action for Nicotinic agonists
Nn(autonomic ganglia): Drugs that have 6 Carbons are selective for thisNm(motor end plate): Drugs that have 10 Carbons are selective for this Nicotine has a greater affinity for nicotinic receptors at ganglia than at motor end-plate receptors
Prolonged/high exposure to nicotine to produce depolarizing blockade of the ganglia (it shuts down…) 
 Overall Ganglionic Stimulation 
Cardiac -- primarily sympathetic responseGI -- primarily parasympathetic response |  | 
        |  | 
        
        | Term 
 
        | Cholinergic agonist How direct acting works
 |  | Definition 
 
        | 
Direct Acting
Have high affinity for receptor and activate receptor
Can be Alkaloids or Choline esters that are synthesized in the lab |  | 
        |  | 
        
        | Term 
 
        | Cholinergic agonist example:  Direct Acting   Acetylcholine |  | Definition 
 
        | 
Acetylcholine
Acts at BOTH Nicotinic and Muscarinic receptor 
Use: Produces complete miosis in eye surgery |  | 
        |  | 
        
        | Term 
 
        | Cholinergic agonist example:  Direct Acting   Methacholine |  | Definition 
 
        | 
Methacholine
Selective at Muscarinic receptor on effector organ 
Add Methyl group to Ach --> less susceptible to Ach-esterase 
Use: Produces complete miosis in eye surgery |  | 
        |  | 
        
        | Term 
 
        | Cholinergic agonist example:  Direct Acting   Carbachol |  | Definition 
 
        | Carbachol 
Addition of amine groupActs at BOTH Nicotinic and Muscarinic receptor; very similar composition to Ach 
Not metabolized by Ach-esteraseUse: Asthma airway hyper-reactivity diagnostic |  | 
        |  | 
        
        | Term 
 
        | Cholinergic agonist example:  Direct Acting   Bethanechol |  | Definition 
 
        | Bethanechol 
Addition of amine AND methyl groupSelective at Muscarinic receptor on effector organAND not metabolized by Ach-esteraseUse: Bladder and GI |  | 
        |  | 
        
        | Term 
 
        | Cholinergic agonist example:  Direct Acting   Muscarine |  | Definition 
 
        | Muscarine 
Selective at Muscarinic receptor on effector organUse: NONE (not used anymore); experimental drug -- Mushrooms!!! |  | 
        |  | 
        
        | Term 
 
        | Cholinergic agonist example:  Direct Acting   Pilocarpine |  | Definition 
 
        | Pilocarpine 
Selective at Muscarinic receptor on effector organUse: Sjogren's Syndrome, Glucoma -- stimulates saliva/tearsNew version on market today: Clevilemine --> used strictly for Sjogren's Syndrome |  | 
        |  | 
        
        | Term 
 
        | Cholinergic agonist example:  Direct Acting   Oxotremorine |  | Definition 
 
        | Oxotremorine 
Selective at Muscarinic receptor on effector organUse: Experimental drug; tool to help develop anti-Parkinson's drugs |  | 
        |  | 
        
        | Term 
 
        | Cholinergic Agonist: Indirect acting |  | Definition 
 
        | 
Indirect Acting
Have low affinity for receptorInhibit activity of Ach-esterase, allowing Ach drug to buildup 
Can be "reversibly" or "irreversible" 
More on this in the section below 
Both Direct and Indirect Acting:
Affect Muscarinic and Nicotinic receptors, increasing their effects |  | 
        |  | 
        
        | Term 
 
        | Absorption, Distribution, and Metabolism of Cholinergic Agonists |  | Definition 
 
        | 
Absorption, Distribution, and Metabolism 
Choline esters are poorly absorbed and poorly distributed into the central nervous system 
Are hydrolyzed in the gastrointestinal tract and are, therefore, less active when given orally 
Choline esters differ markedly in their rate of hydrolysis by cholinesterase (acetylcholinesterase and pseudocholinesterase or butyrylcholinesterase) in the body 
The duration of action of a large iv dose of acetylcholine is only a matter of 5-20 seconds
Addition of a B-methyl group to form methacholine increases resistance to hydrolysis by 3 fold |  | 
        |  | 
        
        | Term 
 
        | 
Mechanism of Cholinergic Agonists |  | Definition 
 
        | 
Mechanism of Cholinergic Agonists
Agonists at Muscarinic Receptors
(Varies in potency and efficacy) 
Activation of the IP3 and DAG cascade 
Increase in cellular concentration of cGMP (indirectly via NO generation --> causes relaxation of smooth muscle)    Inhibition of cAMP formation 
Agonists at Nicotinic Receptors
Nicotinic receptor activation peripherally producesopening of sodium/potassium channels leading to postganglionic neuronal depolarization or neuromuscular end-plate depolarizationIn the CNS nicotinic receptor activation presynaptically increases Ca2+ entry and transmitter release
NT could be Ach, dopamine, serotonin, or some other |  | 
        |  | 
        
        | Term 
 
        | What do Indirect Cholinegic Agonists Do?   Acetlycholinesterase Inhibitors (ACHEI's) |  | Definition 
 
        | 
Blocks hydrolytic action of the enzyme acetylcholinesterase located at the pre- and postsynaptic sites
Leads to an intensification and prolongation of the action of acetylcholine 
Major Uses of ACHEI's(rather limited…)
Chemical warfare agents (nerve gas) 
Treatment of the autoimmune muscular weakness disorder of myasthenia gravis |  | 
        |  | 
        
        | Term 
 
        | What are the three chemical classes of ACHEI's? |  | Definition 
 
        | 
(1) Quaternary ammonium alcohols
Used in diagnostic and special situationsShort duration of action (minutes) 
(2) Tertiary or quaternary ammonium carbamic acid esters
Limited access to organ systems 
Duration is few-several hours 
(3) Organic derivatives of phosphoric acid (organophosphates)
Will attach to enzyme, and can remain their forever -- completely inhibiting itaging - breaking O2 / phosphorus bond making bond stronger => irreversible  |  | 
        |  | 
        
        | Term 
 
        | List examples of Cholinergic Agonists:  Indirect Acting |  | Definition 
 
        | Edrophonium 
Use: Diagnostic tool for Myasthenia GravisAlcohol 
 Neostigmine 
Use: Tx for Myasthenia Gravis
ALSO: post GI surgery, because smooth muscle in GI sometimes 'quits' or 'shuts down' following surgery to it, so this drug stimulates movement again 
 Physostigmine 
 Pyridostigmine 
Use: Tx for Myasthenia Gravis 
 Dysflos 
Use: Eye drops for Glaucoma 
 Eccothiopate 
Use: Tx for GlaucomaOrgansophosphate 
 Parathion |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Autoimmune disease affecting the skeletal muscle neuromuscular junctions (creates muscle weakness) 
An autoimmune response produces antibodies that destroy nicotinic receptors at the postsynaptic site, resulting in muscle weakness
Gap at synapse is widerPits are spread outDensity of receptors are decreased   Treatment 
Pt needs Ach agonist!
Want to stimulate those remaining receptors vigorously Direct agonist do NOT work as well on these ptsBest Tx: Irreversible ACHEI, allowing natural Ach NT to 'do its thing'
NeostigminePyridostigmineAmbenoniumAtropine may be used to counteract the muscarinic side effect
Often tolerance develops to side effects so that atropine is not needed Diagnosis(No idea if this is even important, but he did talk about it) 
Edrophonium: Used in diagnosis and management of myasthenia gravis 
 
Administer Edrophonium Intravenously
If A is converted to B then pt has Myasthenia Gravis
Tx: Pyridostigmine to maintain B 
If A is present on follow-up visit
Adm. edrophonium:
If B occurs
Increase Rx dose of pyridostigmine 
If A persists or gets worse
Decrease dose of Rx pyridostigmine |  | 
        |  |